TL;DR: A 2026 randomized trial in International Journal of Clinical and Health Psychology found that older adults who knowingly took placebo pills for 3 weeks reported lower stress and performed better on Digit Span than controls. Key Findings Aging trial context: The trial randomized 90 healthy community-dwelling adults in Milan, ages 65 to 90, into …
TL;DR: A 2026 review in Translational Neuroscience summarizes why PINK1 and parkin, two genes linked to early-onset parkinsonism, keep pointing researchers back to mitophagy and autophagy as Parkinson disease mechanisms. Key Findings 18 PARK loci noted: The review frames familial Parkinson genetics as a route into molecular mechanisms, including PARK2 and PARK6. PARK2 encodes parkin: …
TL;DR: A 2026 study in Nature Metabolism identified brain hyperglycosylation as a metabolic driver of Alzheimer disease in human tissue and mouse models, while glucosamine exposure was linked to worse outcomes in Alzheimer-related dementia records. Key Findings Human AD brains showed excess glycans: Spatial glycomics found elevated N-glycan abundance in Alzheimer frontal cortex samples compared …
TL;DR: A 2026 preprint in medRxiv found that brain-derived p-tau217%, a blood marker designed to isolate central nervous system tau, classified Alzheimer disease pathology better than standard plasma p-tau217 in several Alzheimer cohorts. Key Findings CNS-selective ratio: The proposed marker, brain-derived p-tau217%, estimates the share of circulating tau that is both brain-derived and phosphorylated at …
TL;DR: A 2025 study in Neurology used a Kaiser Permanente target-trial emulation and found that starting a statin was not linked to higher or lower Alzheimer disease or related dementia incidence after the first year. The first-year diagnosis increase likely reflected more medical contact after a new prescription. Key Findings No difference after year one: …
TL;DR: A 2026 preprint in medRxiv reported that a urine beta-amyloid protein test kit separated mild cognitive impairment or Alzheimer’s disease from healthy controls in a multicenter Chinese sample, while a 51,187-person community screen showed age-related positive rates. Key Findings 898-person validation sample: The multicenter case-control arm included 266 healthy controls, 167 people with mild …
TL;DR: A 2026 preprint on medRxiv found that older adults with mild-cognitive-impairment-level scores showed different resting facial action patterns than healthy controls, especially upper lip raiser, lip tightener, and lip suck measures. Key Findings MCI-level comparison: The study included 45 older adults and compared 31 participants in the MCI-level group with 14 healthy controls. MoCA-defined …
TL;DR: A 2026 narrative review in Neurological Research and Practice argued that Parkinson’s prevention is most actionable through physical activity, Mediterranean-style diet patterns, toxin reduction, earlier prodromal detection, and better rehabilitation after diagnosis. Key Findings Fastest-growing neurological disorder: The review described Parkinson’s disease as the fastest-growing neurological disorder worldwide. 6.2 to 11.8 million cases: A …
TL;DR: A 2026 preprint in medRxiv linked higher neighborhood deprivation to faster DNA-methylation aging in 370 healthy adults, with lifetime adversity explaining part of the association and stronger direct effects among Black participants. Key Findings Yale sample anchored the test: The cross-sectional Yale Stress Center sample included 370 adults aged 18 to 50 years without …
TL;DR: A 2025 human proteomics study in Molecular Metabolism found that about 10 days of medically supervised water-only fasting caused weight loss and lower circulating amyloid beta proteins, but also increased inflammatory and platelet-activation markers. Key Findings 20 volunteers: The main cohort included 20 middle-aged adults with mean age 52.2 years and mean BMI 28.8 …
